No Data
No Data
No Data
No Data
No Data
Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call
MALVERN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who
GlobeNewswireApr 23 16:30 ET
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
MALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who
GlobeNewswireApr 10 08:31 ET
Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression
Yahoo FinanceApr 1 10:52 ET
Neuronetics Inc Shrinks Board Following Strategy Review
TipRanksMar 28 16:27 ET
Top 5 Health Care Stocks That May Plunge In March
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicat
BenzingaMar 28 08:30 ET
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life
GlobeNewswireMar 27 16:30 ET
No Data
No Data